Search research articles
Contact Us
Filters
Showing results (1-10 of 418) with videos related to
Page
of 42
Sort By:
JAMA
|
April 6, 2016
Actinic Keratosis
Mark Lebwohl
Journal of the American Academy of Dermatology
|
August 2, 2003
Combining the new biologic agents with our current psoriasis armamentarium
Mark Lebwohl
Archives of Dermatology
|
May 22, 2002
New developments in the treatment of psoriasis
Mark Lebwohl
Journal of the American Academy of Dermatology
|
May 8, 2020
Comment on "PGA×BSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasis"
Mark Lebwohl
Lancet (London, England)
|
June 9, 2015
Do we need more psoriasis therapies?
Mark Lebwohl
Archives of Dermatology
|
November 21, 2012
Interleukin 12/23 agents and major adverse cardiovascular events
Mark Lebwohl
The Journal of Investigative Dermatology
|
July 25, 2017
Does Treatment of Psoriasis Reduce Cardiovascular Comorbidities?
Mark Lebwohl
Annals of Internal Medicine
|
April 4, 2018
Psoriasis
Mark Lebwohl
Cutis
|
December 7, 2002
Vitamin D and topical therapy
Mark Lebwohl
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2023
Advances in biologic therapy of psoriasis
Mark Lebwohl
Page
of 42
Search research articles
Search
Showing results (1-10 of 418) with videos related to
Sort By:
Page
of 42
JAMA
|
April 6, 2016
Actinic Keratosis
Mark Lebwohl
Journal of the American Academy of Dermatology
|
August 2, 2003
Combining the new biologic agents with our current psoriasis armamentarium
Mark Lebwohl
Archives of Dermatology
|
May 22, 2002
New developments in the treatment of psoriasis
Mark Lebwohl
Journal of the American Academy of Dermatology
|
May 8, 2020
Comment on "PGA×BSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasis"
Mark Lebwohl
Lancet (London, England)
|
June 9, 2015
Do we need more psoriasis therapies?
Mark Lebwohl
Archives of Dermatology
|
November 21, 2012
Interleukin 12/23 agents and major adverse cardiovascular events
Mark Lebwohl
The Journal of Investigative Dermatology
|
July 25, 2017
Does Treatment of Psoriasis Reduce Cardiovascular Comorbidities?
Mark Lebwohl
Annals of Internal Medicine
|
April 4, 2018
Psoriasis
Mark Lebwohl
Cutis
|
December 7, 2002
Vitamin D and topical therapy
Mark Lebwohl
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2023
Advances in biologic therapy of psoriasis
Mark Lebwohl
Page
of 42